CompletedPhase 4

Treatment of Alcohol Withdrawal in Hospital Patients

United States183 participantsStarted 2001-04

Plain-language summary

The purpose of this study is to test how tolerable and effective lorazepam is when used to treat alcohol withdrawal in hospital patients at risk for alcohol withdrawal.

Who can participate

Age range21 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Alcohol dependence (based on criteria from the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition) * Daily alcohol use for at least seven consecutive days with the last use no more than 72 hours prior to enrollment * Patients on the General Internal Medicine service Exclusion Criteria: * Unable to give informed consent * Chronically maintained on prescription sedative-hypnotics

What they're measuring

Withdrawal Assessment Scores

Timeframe: participants were followed for the duration of hospital stay, the median length of stay was 3 days

Total Dose of Lorazepam

Timeframe: participants were followed for the duration of hospital stay, the median length of stay was 3 days

Protocol Errors

Timeframe: participants were followed for the duration of hospital stay, the median length of stay was 3 days

Trial details

NCT IDNCT00249366

SponsorVirginia Commonwealth University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2003-05

View on ClinicalTrials.gov More Alcohol Withdrawal Syndrome trials